Familial hypercholesterolemia (FH) is an inherited disorder of lipid metabolism characterized by the severe elevation of low-density lipoprotein (LDL) particles in the bloodstream. FH affects every racial and ethnic…
Backgroud: Heterozygous familial hypercholesterolemia are either classical cases with high LDL-C levels, tendon xanthomas and LDL receptor gene mutation or probable cases with hypercholesterolemia without known LDL…
genetic condition known as Familial Hypercholesterolemia (FH) causes the body to metabolise cholesterol differently, which leads to elevated levels of LDL cholesterol, generally referred to as "bad" cholesterol. The…
Familial hypercholesterolemia (FH) is an inherited condition that causes high levels of low-density lipoprotein cholesterol (LDL-C) in the blood. The condition is caused by mutations in genes responsible
Familial hypercholesterolemia (FH) is a genetic disorder that results in elevated LDL levels and is associated with an increased risk of cardiovascular disease. HMG-CoA reductase inhibitors are recommended
Familial hypercholesterolemia (FH) is a dominant, autosomal disease characterized by high LDL levels in blood plasma, and is caused by a defect in the gene encoding the LDL receptor (LDLR ... clinical diagnosis is based…
Familial Hypercholesterolemia (FH) is an autosomal codominant disorder characterized by elevated levels of Low Density Lipoprotein Cholesterol (LDL-C). It manifests in both heterozygous and homozygous forms, most…
Familial hypercholesterolemia is an autosomal dominant inherited disorder caused by mutations in the low density lipoprotein receptor gene, the proprotein convertase subtilisin/kexin type 9 gene, the apolipoprotein B…
Background and aims: Familial Hypercholesterolemia (FH) is an inherited metabolic disorder with increased LDL-C levels and coronary heart disease (CHD) risk. The prevalence of heterozygous FH is approximately…
Cardiovascular Diseases and Dr. Ziauddin Hospital, Karachi by performing lipid profiles after overnight fasting. Familial hypercholesterolemia was also diagnosed from premature coronary diseases, xanthomas, arcus…
Introduction: Th e chronicles of Familial Hypercholesterolemia (FH) in the Middle East started sixty years ago with the fi rst description of Essential Hypercholesterolemia in numerous Lebanese families by Khachadurian
Familial hypercholesterolemia is an acquired condition portrayed by exceptionally significant degrees of cholesterol in the blood. Cholesterol is a waxy, fat-like substance that is created in the body ... make specific…
Objectives: Familial hypercholesterolemia (FH) leads to prolonged vascular exposure to high levels of lowdensity lipoprotein cholesterol and subsequent development of atherosclerotic lesions. This study examines…
Objectives: Familial hypercholesterolemia (FH) leads to prolonged vascular exposure to high levels of lowdensity lipoprotein cholesterol and subsequent development of atherosclerotic lesions. This study examines…
report concerns a 12 year old boy with genetically diagnosed compound heterozygous form of familial hypercholesterolemia, who first presented with xanthomas on both knees and elbows and a family history
report concerns a 12-year-old boy with genetically diagnosed compound heterozygous form of familial hypercholesterolemia, who first presented with xanthomas on both knees and elbows and a family history
Objectives: Familial hypercholesterolemia (FH) leads to prolonged vascular exposure to high levels of lowdensity lipoprotein cholesterol and subsequent development of atherosclerotic lesions. This study examines…
Objectives: Familial hypercholesterolemia (FH) leads to prolonged vascular exposure to high levels of lowdensity lipoprotein cholesterol and subsequent development of atherosclerotic lesions. This study examines…
Statement of the Problem: Familial Hypercholesterolemia (FH) is an autosomal dominant disorder caused by the mutation in LDLr gene. In Pakistan the frequency of FH was observed
Statement of the Problem: Homozygous familial hypercholesterolemia (HoFH) is ultra-rare and hard to treat, with high LDL-C and premature major adverse cardiovascular events (MACE). No randomized trials
emerged as a promising approach for addressing cardiovascular diseases such as hypertension, atherosclerosis and Familial Hypercholesterolemia (FH). This review explores the evolution of gene therapy techniques and…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.